Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

SELLAS Life Sciences (SLS) Other Operating Expenses (2019 - 2023)

SELLAS Life Sciences (SLS) has disclosed Other Operating Expenses for 7 consecutive years, with $184000.0 as the latest value for Q1 2023.

  • Quarterly Other Operating Expenses rose 2144.44% to $184000.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $184000.0 through Dec 2023, down 43.21% year-over-year, with the annual reading at $10.1 million for FY2022, 71.19% up from the prior year.
  • Other Operating Expenses for Q1 2023 was $184000.0 at SELLAS Life Sciences, up from $124000.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $5.7 million in Q4 2021, with the low at -$178000.0 in Q1 2019.
  • Average Other Operating Expenses over 5 years is $415466.7, with a median of -$18000.0 recorded in 2019.
  • The sharpest move saw Other Operating Expenses crashed 668.42% in 2021, then surged 2144.44% in 2023.
  • Over 5 years, Other Operating Expenses stood at -$21000.0 in 2019, then soared by 190.48% to $19000.0 in 2020, then skyrocketed by 29900.0% to $5.7 million in 2021, then plummeted by 97.82% to $124000.0 in 2022, then surged by 48.39% to $184000.0 in 2023.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $184000.0, $124000.0, and $209000.0 for Q1 2023, Q3 2022, and Q2 2022 respectively.